Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Figure S7 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Home
Publications
Figure S7 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Figure S7 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Authors:
CZ
Chuanjie Zhang
Chuanjie Zhang
JD
Jiawei Ding
Jiawei Ding
KL
Kiat Shenq Lim
Kiat Shenq Lim
WZ
Wenjie Zhou
Wenjie Zhou
WM
Wenyu Miao
Wenyu Miao
SW
Siqi Wu
Siqi Wu
HL
Hanqing Liu
Hanqing Liu
DH
Da Huang
Da Huang
CC
Chufeng Chen
Chufeng Chen
HH
Hongchao He
Hongchao He
JX
Jun Xiao
Jun Xiao
DX
Dan-Feng Xu
Dan-Feng Xu
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
17 June 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/0008-5472.32702426
Abstract
Assessment of pharmacological or toxicological effect of SKLB325 in treating PCa.
Keywords
GLUTATHIONE METABOLISM
CONFER FERROPTOSIS
FERROPTOSIS RESISTANCE
PROSTATE CANCER
CANCER ASSESSMENT
SPOP-MUTATED PROSTATE
TREATING PCA
TOXICOLOGICAL EFFECT
REWIRES
FIGURE
Related articles
Scroll to top